CHARLES WYKOFF to Clinical Trials as Topic
This is a "connection" page, showing publications CHARLES WYKOFF has written about Clinical Trials as Topic.
Connection Strength
0.813
-
Visual Acuity Variability: Comparing Discrepancies between Snellen and ETDRS Measurements among Subjects Entering Prospective Trials. Ophthalmol Retina. 2021 03; 5(3):224-233.
Score: 0.465
-
Treatment of geographic atrophy: an update on data related to pegcetacoplan. Curr Opin Ophthalmol. 2024 Jan 01; 35(1):64-72.
Score: 0.148
-
Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases. Am J Ophthalmol. 2017 Aug; 180:8-17.
Score: 0.095
-
New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway. Eye (Lond). 2025 Dec; 39(18):3209-3217.
Score: 0.042
-
Re: Minimizing risks to patients by improving presentation of clinical trial results in geographic atrophy trials (Ophthalmol Retina. 2022;6:337-338). Ophthalmol Retina. 2022 11; 6(11):1109.
Score: 0.035
-
Abicipar pegol for neovascular age-related macular degeneration. Expert Opin Biol Ther. 2020 09; 20(9):999-1008.
Score: 0.029